Cognitive deficits in people who have recovered from COVID-19
There is growing concern about possible cognitive consequences of COVID-19, with reports of ‘Long COVID’ symptoms persisting into the chronic phase and case studies revealing neurological problems in severely affected patients. However, there is little information regarding the nature and broader pr...
Gespeichert in:
| Veröffentlicht in: | EClinicalMedicine Jg. 39; S. 101044 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
Elsevier Ltd
01.09.2021
Elsevier |
| Schlagworte: | |
| ISSN: | 2589-5370, 2589-5370 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | There is growing concern about possible cognitive consequences of COVID-19, with reports of ‘Long COVID’ symptoms persisting into the chronic phase and case studies revealing neurological problems in severely affected patients. However, there is little information regarding the nature and broader prevalence of cognitive problems post-infection or across the full spread of disease severity.
We sought to confirm whether there was an association between cross-sectional cognitive performance data from 81,337 participants who between January and December 2020 undertook a clinically validated web-optimized assessment as part of the Great British Intelligence Test, and questionnaire items capturing self-report of suspected and confirmed COVID-19 infection and respiratory symptoms.
People who had recovered from COVID-19, including those no longer reporting symptoms, exhibited significant cognitive deficits versus controls when controlling for age, gender, education level, income, racial-ethnic group, pre-existing medical disorders, tiredness, depression and anxiety. The deficits were of substantial effect size for people who had been hospitalised (N = 192), but also for non-hospitalised cases who had biological confirmation of COVID-19 infection (N = 326). Analysing markers of premorbid intelligence did not support these differences being present prior to infection. Finer grained analysis of performance across sub-tests supported the hypothesis that COVID-19 has a multi-domain impact on human cognition.
Interpretation. These results accord with reports of ‘Long Covid’ cognitive symptoms that persist into the early-chronic phase. They should act as a clarion call for further research with longitudinal and neuroimaging cohorts to plot recovery trajectories and identify the biological basis of cognitive deficits in SARS-COV-2 survivors.
Funding. AH is supported by the UK Dementia Research Institute Care Research and Technology Centre and Biomedical Research Centre at Imperial College London. WT is supported by the EPSRC Centre for Doctoral Training in Neurotechnology. SRC is funded by a Wellcome Trust Clinical Fellowship 110,049/Z/15/Z. JMB is supported by Medical Research Council (MR/N013700/1). MAM, SCRW and PJH are, in part, supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London |
|---|---|
| AbstractList | AbstractBackgroundThere is growing concern about possible cognitive consequences of COVID-19, with reports of ‘Long COVID’ symptoms persisting into the chronic phase and case studies revealing neurological problems in severely affected patients. However, there is little information regarding the nature and broader prevalence of cognitive problems post-infection or across the full spread of disease severity. MethodsWe sought to confirm whether there was an association between cross-sectional cognitive performance data from 81,337 participants who between January and December 2020 undertook a clinically validated web-optimized assessment as part of the Great British Intelligence Test, and questionnaire items capturing self-report of suspected and confirmed COVID-19 infection and respiratory symptoms. FindingsPeople who had recovered from COVID-19, including those no longer reporting symptoms, exhibited significant cognitive deficits versus controls when controlling for age, gender, education level, income, racial-ethnic group, pre-existing medical disorders, tiredness, depression and anxiety. The deficits were of substantial effect size for people who had been hospitalised ( N = 192), but also for non-hospitalised cases who had biological confirmation of COVID-19 infection ( N = 326). Analysing markers of premorbid intelligence did not support these differences being present prior to infection. Finer grained analysis of performance across sub-tests supported the hypothesis that COVID-19 has a multi-domain impact on human cognition. InterpretationInterpretation. These results accord with reports of ‘Long Covid’ cognitive symptoms that persist into the early-chronic phase. They should act as a clarion call for further research with longitudinal and neuroimaging cohorts to plot recovery trajectories and identify the biological basis of cognitive deficits in SARS-COV-2 survivors. FundingFunding. AH is supported by the UK Dementia Research Institute Care Research and Technology Centre and Biomedical Research Centre at Imperial College London. WT is supported by the EPSRC Centre for Doctoral Training in Neurotechnology. SRC is funded by a Wellcome Trust Clinical Fellowship 110,049/Z/15/Z. JMB is supported by Medical Research Council (MR/N013700/1). MAM, SCRW and PJH are, in part, supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London Background: There is growing concern about possible cognitive consequences of COVID-19, with reports of ‘Long COVID’ symptoms persisting into the chronic phase and case studies revealing neurological problems in severely affected patients. However, there is little information regarding the nature and broader prevalence of cognitive problems post-infection or across the full spread of disease severity. Methods: We sought to confirm whether there was an association between cross-sectional cognitive performance data from 81,337 participants who between January and December 2020 undertook a clinically validated web-optimized assessment as part of the Great British Intelligence Test, and questionnaire items capturing self-report of suspected and confirmed COVID-19 infection and respiratory symptoms. Findings: People who had recovered from COVID-19, including those no longer reporting symptoms, exhibited significant cognitive deficits versus controls when controlling for age, gender, education level, income, racial-ethnic group, pre-existing medical disorders, tiredness, depression and anxiety. The deficits were of substantial effect size for people who had been hospitalised (N = 192), but also for non-hospitalised cases who had biological confirmation of COVID-19 infection (N = 326). Analysing markers of premorbid intelligence did not support these differences being present prior to infection. Finer grained analysis of performance across sub-tests supported the hypothesis that COVID-19 has a multi-domain impact on human cognition. Interpretation: Interpretation. These results accord with reports of ‘Long Covid’ cognitive symptoms that persist into the early-chronic phase. They should act as a clarion call for further research with longitudinal and neuroimaging cohorts to plot recovery trajectories and identify the biological basis of cognitive deficits in SARS-COV-2 survivors. Funding: Funding. AH is supported by the UK Dementia Research Institute Care Research and Technology Centre and Biomedical Research Centre at Imperial College London. WT is supported by the EPSRC Centre for Doctoral Training in Neurotechnology. SRC is funded by a Wellcome Trust Clinical Fellowship 110,049/Z/15/Z. JMB is supported by Medical Research Council (MR/N013700/1). MAM, SCRW and PJH are, in part, supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London There is growing concern about possible cognitive consequences of COVID-19, with reports of 'Long COVID' symptoms persisting into the chronic phase and case studies revealing neurological problems in severely affected patients. However, there is little information regarding the nature and broader prevalence of cognitive problems post-infection or across the full spread of disease severity. We sought to confirm whether there was an association between cross-sectional cognitive performance data from 81,337 participants who between January and December 2020 undertook a clinically validated web-optimized assessment as part of the Great British Intelligence Test, and questionnaire items capturing self-report of suspected and confirmed COVID-19 infection and respiratory symptoms. People who had recovered from COVID-19, including those no longer reporting symptoms, exhibited significant cognitive deficits versus controls when controlling for age, gender, education level, income, racial-ethnic group, pre-existing medical disorders, tiredness, depression and anxiety. The deficits were of substantial effect size for people who had been hospitalised ( = 192), but also for non-hospitalised cases who had biological confirmation of COVID-19 infection ( = 326). Analysing markers of premorbid intelligence did not support these differences being present prior to infection. Finer grained analysis of performance across sub-tests supported the hypothesis that COVID-19 has a multi-domain impact on human cognition. Interpretation. These results accord with reports of 'Long Covid' cognitive symptoms that persist into the early-chronic phase. They should act as a clarion call for further research with longitudinal and neuroimaging cohorts to plot recovery trajectories and identify the biological basis of cognitive deficits in SARS-COV-2 survivors. Funding. AH is supported by the UK Dementia Research Institute Care Research and Technology Centre and Biomedical Research Centre at Imperial College London. WT is supported by the EPSRC Centre for Doctoral Training in Neurotechnology. SRC is funded by a Wellcome Trust Clinical Fellowship 110,049/Z/15/Z. JMB is supported by Medical Research Council (MR/N013700/1). MAM, SCRW and PJH are, in part, supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. There is growing concern about possible cognitive consequences of COVID-19, with reports of ‘Long COVID’ symptoms persisting into the chronic phase and case studies revealing neurological problems in severely affected patients. However, there is little information regarding the nature and broader prevalence of cognitive problems post-infection or across the full spread of disease severity. We sought to confirm whether there was an association between cross-sectional cognitive performance data from 81,337 participants who between January and December 2020 undertook a clinically validated web-optimized assessment as part of the Great British Intelligence Test, and questionnaire items capturing self-report of suspected and confirmed COVID-19 infection and respiratory symptoms. People who had recovered from COVID-19, including those no longer reporting symptoms, exhibited significant cognitive deficits versus controls when controlling for age, gender, education level, income, racial-ethnic group, pre-existing medical disorders, tiredness, depression and anxiety. The deficits were of substantial effect size for people who had been hospitalised (N = 192), but also for non-hospitalised cases who had biological confirmation of COVID-19 infection (N = 326). Analysing markers of premorbid intelligence did not support these differences being present prior to infection. Finer grained analysis of performance across sub-tests supported the hypothesis that COVID-19 has a multi-domain impact on human cognition. Interpretation. These results accord with reports of ‘Long Covid’ cognitive symptoms that persist into the early-chronic phase. They should act as a clarion call for further research with longitudinal and neuroimaging cohorts to plot recovery trajectories and identify the biological basis of cognitive deficits in SARS-COV-2 survivors. Funding. AH is supported by the UK Dementia Research Institute Care Research and Technology Centre and Biomedical Research Centre at Imperial College London. WT is supported by the EPSRC Centre for Doctoral Training in Neurotechnology. SRC is funded by a Wellcome Trust Clinical Fellowship 110,049/Z/15/Z. JMB is supported by Medical Research Council (MR/N013700/1). MAM, SCRW and PJH are, in part, supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London There is growing concern about possible cognitive consequences of COVID-19, with reports of 'Long COVID' symptoms persisting into the chronic phase and case studies revealing neurological problems in severely affected patients. However, there is little information regarding the nature and broader prevalence of cognitive problems post-infection or across the full spread of disease severity.BACKGROUNDThere is growing concern about possible cognitive consequences of COVID-19, with reports of 'Long COVID' symptoms persisting into the chronic phase and case studies revealing neurological problems in severely affected patients. However, there is little information regarding the nature and broader prevalence of cognitive problems post-infection or across the full spread of disease severity.We sought to confirm whether there was an association between cross-sectional cognitive performance data from 81,337 participants who between January and December 2020 undertook a clinically validated web-optimized assessment as part of the Great British Intelligence Test, and questionnaire items capturing self-report of suspected and confirmed COVID-19 infection and respiratory symptoms.METHODSWe sought to confirm whether there was an association between cross-sectional cognitive performance data from 81,337 participants who between January and December 2020 undertook a clinically validated web-optimized assessment as part of the Great British Intelligence Test, and questionnaire items capturing self-report of suspected and confirmed COVID-19 infection and respiratory symptoms.People who had recovered from COVID-19, including those no longer reporting symptoms, exhibited significant cognitive deficits versus controls when controlling for age, gender, education level, income, racial-ethnic group, pre-existing medical disorders, tiredness, depression and anxiety. The deficits were of substantial effect size for people who had been hospitalised (N = 192), but also for non-hospitalised cases who had biological confirmation of COVID-19 infection (N = 326). Analysing markers of premorbid intelligence did not support these differences being present prior to infection. Finer grained analysis of performance across sub-tests supported the hypothesis that COVID-19 has a multi-domain impact on human cognition.FINDINGSPeople who had recovered from COVID-19, including those no longer reporting symptoms, exhibited significant cognitive deficits versus controls when controlling for age, gender, education level, income, racial-ethnic group, pre-existing medical disorders, tiredness, depression and anxiety. The deficits were of substantial effect size for people who had been hospitalised (N = 192), but also for non-hospitalised cases who had biological confirmation of COVID-19 infection (N = 326). Analysing markers of premorbid intelligence did not support these differences being present prior to infection. Finer grained analysis of performance across sub-tests supported the hypothesis that COVID-19 has a multi-domain impact on human cognition.Interpretation. These results accord with reports of 'Long Covid' cognitive symptoms that persist into the early-chronic phase. They should act as a clarion call for further research with longitudinal and neuroimaging cohorts to plot recovery trajectories and identify the biological basis of cognitive deficits in SARS-COV-2 survivors.INTERPRETATIONInterpretation. These results accord with reports of 'Long Covid' cognitive symptoms that persist into the early-chronic phase. They should act as a clarion call for further research with longitudinal and neuroimaging cohorts to plot recovery trajectories and identify the biological basis of cognitive deficits in SARS-COV-2 survivors.Funding. AH is supported by the UK Dementia Research Institute Care Research and Technology Centre and Biomedical Research Centre at Imperial College London. WT is supported by the EPSRC Centre for Doctoral Training in Neurotechnology. SRC is funded by a Wellcome Trust Clinical Fellowship 110,049/Z/15/Z. JMB is supported by Medical Research Council (MR/N013700/1). MAM, SCRW and PJH are, in part, supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London.FUNDINGFunding. AH is supported by the UK Dementia Research Institute Care Research and Technology Centre and Biomedical Research Centre at Imperial College London. WT is supported by the EPSRC Centre for Doctoral Training in Neurotechnology. SRC is funded by a Wellcome Trust Clinical Fellowship 110,049/Z/15/Z. JMB is supported by Medical Research Council (MR/N013700/1). MAM, SCRW and PJH are, in part, supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. |
| ArticleNumber | 101044 |
| Author | Hellyer, Peter Patrick, Fiona Barnby, Joseph M Jolly, Amy E. Hampshire, Adam Mehta, Mitul A Chamberlain, Samuel R Grant, Jon E. Mazibuko, Ndaba Trender, William Williams, Steve CR |
| Author_xml | – sequence: 1 givenname: Adam orcidid: 0000-0002-5176-5420 surname: Hampshire fullname: Hampshire, Adam email: a.hampshire@imperial.ac.uk organization: Department of Brain Sciences, Dementia Research Institute Care Research and Technology Centre, Imperial College London, 926, Sir Michael Uren Hub 86 Wood Lane, London, W12 0BZ – sequence: 2 givenname: William orcidid: 0000-0003-3947-5532 surname: Trender fullname: Trender, William organization: Department of Brain Sciences, Dementia Research Institute Care Research and Technology Centre, Imperial College London, 926, Sir Michael Uren Hub 86 Wood Lane, London, W12 0BZ – sequence: 3 givenname: Samuel R surname: Chamberlain fullname: Chamberlain, Samuel R organization: Department of Psychiatry, University of Southampton, United Kingdom – sequence: 4 givenname: Amy E. orcidid: 0000-0002-7413-9772 surname: Jolly fullname: Jolly, Amy E. organization: Department of Brain Sciences, Dementia Research Institute Care Research and Technology Centre, Imperial College London, 926, Sir Michael Uren Hub 86 Wood Lane, London, W12 0BZ – sequence: 5 givenname: Jon E. surname: Grant fullname: Grant, Jon E. organization: Department of Psychiatry, University of Chicago, United States – sequence: 6 givenname: Fiona surname: Patrick fullname: Patrick, Fiona organization: Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom – sequence: 7 givenname: Ndaba surname: Mazibuko fullname: Mazibuko, Ndaba organization: Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom – sequence: 8 givenname: Steve CR surname: Williams fullname: Williams, Steve CR organization: Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom – sequence: 9 givenname: Joseph M surname: Barnby fullname: Barnby, Joseph M organization: Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom – sequence: 10 givenname: Peter surname: Hellyer fullname: Hellyer, Peter organization: Department of Brain Sciences, Dementia Research Institute Care Research and Technology Centre, Imperial College London, 926, Sir Michael Uren Hub 86 Wood Lane, London, W12 0BZ – sequence: 11 givenname: Mitul A surname: Mehta fullname: Mehta, Mitul A organization: Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34316551$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVkltvEzEQhVeoiJbSf4DQPvKSML7uGgESCrdIlfpAxavltWcTh8062Jug_nu8bIpaJFTxZGvmzHekOfO0OOlDj0XxnMCcAJGvNnO0ne-3cwqUjCXg_FFxRkWtZoJVcHLnf1pcpLQBAAq8VhKeFKeMMyKFIGfF20VY9X7wBywdtt76IZW-L3cYdh2WP9ehXJvci2jDASO6so1hWy6uvi0_zIh6VjxuTZfw4vieF9efPl4vvswurz4vF-8vZ7YCNsyok8BNTQRKXhnmaotUtkY2tQPTWIrUIZcGREu5lOAqdAyUIYoxqUzDzovlhHXBbPQu-q2JNzoYr38XQlxpEwdvO9SiajjHmlkQhquWKKx4JXnbNKwxXFSZ9W5i7fbNFp3Ffoimuwe93-n9Wq_CQddU1YSpDHh5BMTwY49p0FufLHad6THsk6ZCCCVFLWWWvrjr9cfkdv1Z8HoS2BhSitjqHIAZfBitfacJ6DFuvdFT3HqMW09x52H-1_At_4Gx4wIwB3bwGHWyHnuLzueUh7xS_7-AUeOt6b7jDaZN2Mc-H4MmOlEN-ut4iOMdUgLAKKcZ8ObfgIf9fwEb4O0B |
| CitedBy_id | crossref_primary_10_1056_NEJMoa2311330 crossref_primary_10_1186_s40359_024_01740_7 crossref_primary_10_1016_j_ebiom_2022_104211 crossref_primary_10_1186_s40779_022_00431_x crossref_primary_10_1371_journal_pone_0271425 crossref_primary_10_1186_s41983_022_00505_6 crossref_primary_10_1080_09638288_2025_2521000 crossref_primary_10_1038_s41467_022_30932_1 crossref_primary_10_1080_19012276_2022_2074525 crossref_primary_10_1093_arclin_acae071 crossref_primary_10_3390_jcm11123440 crossref_primary_10_1212_WNL_0000000000208073 crossref_primary_10_1007_s00115_022_01297_z crossref_primary_10_3390_healthcare12161624 crossref_primary_10_1093_brain_awae416 crossref_primary_10_1016_j_pmr_2023_03_005 crossref_primary_10_1055_a_1946_3230 crossref_primary_10_1093_brain_awac113 crossref_primary_10_1007_s00415_023_11587_4 crossref_primary_10_3390_jcm14176007 crossref_primary_10_1371_journal_pone_0269353 crossref_primary_10_7759_cureus_67815 crossref_primary_10_1016_j_concog_2023_103464 crossref_primary_10_3389_fpubh_2023_1185957 crossref_primary_10_1016_j_neuroscience_2025_08_047 crossref_primary_10_1002_brb3_2902 crossref_primary_10_1080_23744235_2025_2551665 crossref_primary_10_1016_S2215_0366_24_00214_1 crossref_primary_10_3390_ijerph20010183 crossref_primary_10_3390_nu14020333 crossref_primary_10_1007_s40211_023_00487_8 crossref_primary_10_1016_j_bbih_2024_100857 crossref_primary_10_26633_RPSP_2022_108 crossref_primary_10_1001_jamanetworkopen_2023_11974 crossref_primary_10_1016_j_ergon_2025_103741 crossref_primary_10_7717_peerj_16669 crossref_primary_10_1016_j_bbih_2023_100691 crossref_primary_10_1042_BCJ20220154 crossref_primary_10_3390_cells12222601 crossref_primary_10_3389_fresc_2021_754468 crossref_primary_10_5582_bst_2023_01039 crossref_primary_10_1016_j_amjmed_2024_01_021 crossref_primary_10_1002_jmv_28524 crossref_primary_10_1007_s10072_022_06562_2 crossref_primary_10_1002_EXP_20230029 crossref_primary_10_1016_j_bbi_2024_12_002 crossref_primary_10_1007_s11055_023_01474_w crossref_primary_10_1007_s11055_022_01286_4 crossref_primary_10_23736_S1973_9087_21_07384_6 crossref_primary_10_1183_23120541_00013_2023 crossref_primary_10_1016_j_neubiorev_2025_106067 crossref_primary_10_1007_s11357_024_01324_8 crossref_primary_10_1038_s41590_022_01410_z crossref_primary_10_31083_j_fbe1404027 crossref_primary_10_1016_j_bbih_2023_100587 crossref_primary_10_3389_fnins_2023_1180868 crossref_primary_10_1016_j_cct_2022_106955 crossref_primary_10_1002_path_5878 crossref_primary_10_1038_s41398_024_03108_2 crossref_primary_10_1002_alz_14219 crossref_primary_10_1016_j_psychres_2023_115375 crossref_primary_10_1080_13854046_2022_2030412 crossref_primary_10_1111_ene_15721 crossref_primary_10_1038_s41380_024_02554_0 crossref_primary_10_9778_cmajo_20220248 crossref_primary_10_1242_dmm_049376 crossref_primary_10_1007_s00221_023_06545_5 crossref_primary_10_1016_S2215_0366_22_00302_9 crossref_primary_10_3233_RNN_211249 crossref_primary_10_3390_biomedicines13010069 crossref_primary_10_1093_biomethods_bpaf006 crossref_primary_10_1002_pmrj_12745 crossref_primary_10_3390_ijerph20186760 crossref_primary_10_1093_infdis_jiae242 crossref_primary_10_1161_ATVBAHA_124_320798 crossref_primary_10_3389_fpsyg_2022_770459 crossref_primary_10_1080_00207454_2022_2084091 crossref_primary_10_3389_fnagi_2022_958744 crossref_primary_10_3389_fnins_2025_1576393 crossref_primary_10_1016_j_tics_2023_08_008 crossref_primary_10_14814_phy2_15391 crossref_primary_10_3390_life15050821 crossref_primary_10_1053_j_jvca_2021_09_051 crossref_primary_10_1002_adbi_202101166 crossref_primary_10_1186_s12879_024_10158_w crossref_primary_10_3390_jcm12031198 crossref_primary_10_1016_j_heliyon_2024_e37193 crossref_primary_10_1111_ene_15215 crossref_primary_10_1002_hbm_26163 crossref_primary_10_1016_j_bbi_2023_01_010 crossref_primary_10_1038_s41590_024_01868_z crossref_primary_10_3389_fnhum_2025_1571477 crossref_primary_10_1002_brb3_3415 crossref_primary_10_3390_medicina58101401 crossref_primary_10_1186_s12991_023_00435_4 crossref_primary_10_3389_fmed_2022_1027853 crossref_primary_10_1080_00918369_2024_2309497 crossref_primary_10_1016_j_euroneuro_2022_12_002 crossref_primary_10_3390_jcm11216554 crossref_primary_10_3390_cells11193124 crossref_primary_10_1016_j_ajp_2022_103438 crossref_primary_10_1016_j_lanwpc_2023_100836 crossref_primary_10_1038_s41598_025_09128_2 crossref_primary_10_1002_npr2_12466 crossref_primary_10_1038_s41598_023_42429_y crossref_primary_10_17533_udea_iatreia_264 crossref_primary_10_3389_fpsyg_2023_1233144 crossref_primary_10_1038_d41586_022_04253_8 crossref_primary_10_1136_bmjopen_2023_072611 crossref_primary_10_3389_fneur_2022_1029302 crossref_primary_10_1002_acp_70040 crossref_primary_10_1080_13803395_2025_2544730 crossref_primary_10_3233_HSM_220003 crossref_primary_10_3389_fneur_2022_915712 crossref_primary_10_3389_fneur_2024_1367974 crossref_primary_10_1177_17562864221111995 crossref_primary_10_3389_fimmu_2022_872542 crossref_primary_10_1027_2157_3891_a000068 crossref_primary_10_1111_ene_70195 crossref_primary_10_3390_covid5090153 crossref_primary_10_3390_brainsci13121670 crossref_primary_10_1038_s41598_024_69772_y crossref_primary_10_3390_encyclopedia2010024 crossref_primary_10_1016_j_neubiorev_2022_105000 crossref_primary_10_1186_s13256_023_04300_6 crossref_primary_10_1515_hmbci_2022_0015 crossref_primary_10_7256_2454_0722_2025_2_71082 crossref_primary_10_1016_j_cortex_2025_04_004 crossref_primary_10_21603_sibscript_2024_26_2_196_209 crossref_primary_10_3390_vaccines10060849 crossref_primary_10_3390_ijerph20021361 crossref_primary_10_1002_jnr_70051 crossref_primary_10_3390_microorganisms13010090 crossref_primary_10_1097_WCO_0000000000001051 crossref_primary_10_1002_alz_12993 crossref_primary_10_1038_s41598_024_54613_9 crossref_primary_10_3390_antiox11010140 crossref_primary_10_1017_S1355617722000777 crossref_primary_10_1080_13854046_2025_2451247 crossref_primary_10_1002_mhs2_70027 crossref_primary_10_3389_fpsyg_2021_782866 crossref_primary_10_3390_brainsci14060587 crossref_primary_10_1073_pnas_2217232120 crossref_primary_10_1038_s41598_022_09410_7 crossref_primary_10_1093_arclin_acae017 crossref_primary_10_1007_s42843_022_00056_7 crossref_primary_10_1016_j_expneurol_2024_114917 crossref_primary_10_1001_jamanetworkopen_2023_56098 crossref_primary_10_1007_s11065_024_09642_6 crossref_primary_10_1007_s44192_025_00193_7 crossref_primary_10_1016_j_rdc_2024_08_004 crossref_primary_10_1002_brb3_3303 crossref_primary_10_1093_ofid_ofad320 crossref_primary_10_3389_fpubh_2023_1306132 crossref_primary_10_3389_fimmu_2024_1290523 crossref_primary_10_1136_bmjopen_2022_069243 crossref_primary_10_1093_jnen_nlac095 crossref_primary_10_1186_s12879_022_07062_6 crossref_primary_10_1080_23279095_2025_2469261 crossref_primary_10_1136_bmj_2021_069868 crossref_primary_10_3389_fneur_2025_1549195 crossref_primary_10_1097_WCO_0000000000001046 crossref_primary_10_1007_s10072_022_06285_4 crossref_primary_10_1007_s10608_022_10336_7 crossref_primary_10_1038_s41598_025_04166_2 crossref_primary_10_1038_s41746_024_01327_x crossref_primary_10_1177_15459683211054175 crossref_primary_10_1097_CPT_0000000000000217 crossref_primary_10_3389_fnins_2023_1004957 crossref_primary_10_1111_jocn_16665 crossref_primary_10_1097_NMD_0000000000001702 crossref_primary_10_3389_fcell_2022_978142 crossref_primary_10_1016_j_bbi_2025_07_002 crossref_primary_10_1016_j_jpsychores_2023_111441 crossref_primary_10_1080_13854046_2024_2392943 crossref_primary_10_5498_wjp_v12_i8_1004 crossref_primary_10_1016_j_arr_2023_101962 crossref_primary_10_1007_s41999_021_00575_4 crossref_primary_10_3389_fneur_2024_1401796 crossref_primary_10_1007_s10072_021_05798_8 crossref_primary_10_3233_NRE_228020 crossref_primary_10_3390_challe12020028 crossref_primary_10_1038_s43587_022_00321_w crossref_primary_10_3389_fpsyg_2023_1183789 crossref_primary_10_1016_j_bbi_2024_05_001 crossref_primary_10_3892_etm_2022_11424 crossref_primary_10_3389_fnhum_2024_1409250 crossref_primary_10_3390_healthcare10101891 crossref_primary_10_1016_j_dajour_2022_100137 crossref_primary_10_3390_pathogens10101267 crossref_primary_10_1016_j_comppsych_2025_152598 crossref_primary_10_3390_biom15070928 crossref_primary_10_3390_biomedicines11082228 crossref_primary_10_1007_s00406_023_01638_2 crossref_primary_10_1016_j_ajp_2022_103409 crossref_primary_10_1038_s41598_024_52005_7 crossref_primary_10_1016_j_pscychresns_2023_111746 crossref_primary_10_3233_JAD_220105 crossref_primary_10_1038_s41380_023_02057_4 crossref_primary_10_3389_fphar_2022_925879 crossref_primary_10_1016_j_bbih_2025_100997 crossref_primary_10_3389_fneur_2023_1239182 crossref_primary_10_1016_S2213_2600_21_00385_4 crossref_primary_10_1016_j_bbih_2022_100454 crossref_primary_10_1016_j_ijid_2024_107263 crossref_primary_10_1053_j_semnuclmed_2025_06_001 crossref_primary_10_1002_acn3_51801 crossref_primary_10_1136_bmj_2024_081349 crossref_primary_10_1002_acp_4139 crossref_primary_10_1038_s41467_025_62156_4 crossref_primary_10_1002_wjo2_175 crossref_primary_10_1111_anae_15627 crossref_primary_10_1007_s00415_022_11444_w crossref_primary_10_1017_neu_2022_13 crossref_primary_10_3390_bs15040432 crossref_primary_10_1016_j_cortex_2025_05_019 crossref_primary_10_1136_bmj_2021_067883 crossref_primary_10_1177_02698811251346729 crossref_primary_10_1007_s00406_023_01741_4 crossref_primary_10_3390_ijerph20064889 crossref_primary_10_1055_s_0042_1743445 crossref_primary_10_3390_biom12111646 crossref_primary_10_1177_15500594241252484 crossref_primary_10_3390_jpm14030313 crossref_primary_10_1161_STROKEAHA_124_046821 crossref_primary_10_1371_journal_pone_0273352 crossref_primary_10_1371_journal_pmed_1004511 crossref_primary_10_1016_j_tins_2025_01_003 crossref_primary_10_1186_s43045_022_00245_6 crossref_primary_10_3389_fimmu_2024_1341600 crossref_primary_10_3389_fpsyt_2022_782144 crossref_primary_10_1016_j_neuarg_2025_01_003 crossref_primary_10_1371_journal_pmed_1004092 crossref_primary_10_1002_acn3_51496 crossref_primary_10_1007_s00406_024_01863_3 crossref_primary_10_1016_j_ejphar_2023_175647 crossref_primary_10_2196_30259 crossref_primary_10_1016_j_jns_2022_120151 crossref_primary_10_1038_s41591_024_03309_8 crossref_primary_10_3390_ijerph19137748 crossref_primary_10_3389_fpsyg_2025_1588477 crossref_primary_10_1016_j_ijsu_2022_106895 crossref_primary_10_1136_bmjopen_2021_056366 crossref_primary_10_1136_bmjopen_2021_055038 crossref_primary_10_3390_ctn6020009 crossref_primary_10_1093_gerona_glaf097 crossref_primary_10_3389_fpubh_2023_1228008 crossref_primary_10_1038_s41746_024_01124_6 crossref_primary_10_1093_brain_awae101 crossref_primary_10_3390_covid5070100 crossref_primary_10_1038_s41598_024_62050_x crossref_primary_10_3389_fpsyt_2022_801135 crossref_primary_10_3390_jcm10225225 crossref_primary_10_1016_j_psc_2022_07_009 crossref_primary_10_3390_v15102020 crossref_primary_10_1097_MD_0000000000037502 crossref_primary_10_1016_j_euroneuro_2022_04_004 crossref_primary_10_1016_j_psychres_2022_114822 crossref_primary_10_1080_23279095_2025_2502871 crossref_primary_10_1136_bmjresp_2023_001647 crossref_primary_10_3390_neurolint15020045 crossref_primary_10_1016_j_actpsy_2023_103838 crossref_primary_10_3390_systems9040073 crossref_primary_10_1097_MD_0000000000035210 crossref_primary_10_1111_jnc_15736 crossref_primary_10_3389_fnagi_2022_1077384 crossref_primary_10_3390_brainsci12010059 crossref_primary_10_1186_s13063_024_08554_3 crossref_primary_10_3389_fmicb_2022_963488 crossref_primary_10_3390_jcm12113702 crossref_primary_10_1016_j_banm_2023_06_009 crossref_primary_10_1016_j_nsa_2023_103932 crossref_primary_10_1007_s42399_022_01352_5 crossref_primary_10_3389_fnagi_2022_804937 crossref_primary_10_3390_brainsci13091275 crossref_primary_10_1007_s00406_024_01904_x crossref_primary_10_1016_j_cortex_2022_06_002 crossref_primary_10_26565_2312_5675_2024_26_03 crossref_primary_10_3389_fneur_2022_919596 crossref_primary_10_3389_fnhum_2024_1468204 crossref_primary_10_3390_healthcare11030284 crossref_primary_10_1007_s00415_023_12069_3 crossref_primary_10_1192_j_eurpsy_2023_25 crossref_primary_10_1093_ijpp_riac026 crossref_primary_10_1016_j_rehab_2023_101737 crossref_primary_10_3390_s22166312 crossref_primary_10_1016_j_arr_2024_102448 crossref_primary_10_1080_15548627_2025_2562882 crossref_primary_10_1186_s12879_025_11468_3 crossref_primary_10_3390_neurolint16020028 crossref_primary_10_3389_fpubh_2022_1085319 crossref_primary_10_1016_j_jocn_2023_09_005 crossref_primary_10_3390_v14102270 crossref_primary_10_3390_bioengineering10040435 crossref_primary_10_1007_s00415_023_11913_w crossref_primary_10_3389_fneur_2022_904796 crossref_primary_10_1093_arclin_acac004 crossref_primary_10_3917_cerpsy_136_0009 crossref_primary_10_1186_s13024_023_00672_x crossref_primary_10_1002_jmv_70579 crossref_primary_10_1007_s13760_022_02001_3 crossref_primary_10_1016_j_tjpad_2025_100370 crossref_primary_10_1016_j_bbih_2022_100491 crossref_primary_10_1038_s41380_022_01656_x crossref_primary_10_1016_j_bbi_2024_11_007 crossref_primary_10_1177_15500594221103834 crossref_primary_10_3390_jcm12227049 crossref_primary_10_1016_j_clinph_2024_01_010 crossref_primary_10_3390_healthcare10101839 crossref_primary_10_3390_v15010256 crossref_primary_10_1186_s13024_022_00565_5 crossref_primary_10_1080_13548506_2025_2496831 crossref_primary_10_3390_brainsci13010084 crossref_primary_10_3390_brainsci15060635 crossref_primary_10_1007_s00221_021_06244_z crossref_primary_10_1017_S0033291722001374 crossref_primary_10_3390_biomedicines12071574 crossref_primary_10_7759_cureus_58929 crossref_primary_10_1016_j_rmr_2024_07_009 crossref_primary_10_1186_s12883_023_03465_3 crossref_primary_10_1016_j_jped_2021_08_003 crossref_primary_10_3390_jcm11247338 crossref_primary_10_1136_bmj_2022_071050 crossref_primary_10_3390_jcm11195529 crossref_primary_10_1038_s41591_023_02525_y crossref_primary_10_1111_pcn_13855 crossref_primary_10_1177_20503121231194400 crossref_primary_10_1038_s41380_022_01632_5 crossref_primary_10_1136_bmjopen_2023_082902 crossref_primary_10_1001_jamanetworkopen_2025_5532 crossref_primary_10_1111_ene_16181 crossref_primary_10_3389_fpsyg_2021_724022 crossref_primary_10_3390_biomedicines10040772 |
| Cites_doi | 10.1007/s00701-020-04374-x 10.1093/brain/awaa240 10.1016/S2215-0366(20)30168-1 10.1186/s13054-019-2626-z 10.1016/S2215-0366(20)30203-0 10.1016/S2215-0366(20)30287-X 10.1056/NEJMc2009191 10.1016/j.neuron.2012.06.022 10.1136/jnnp-2020-323667 10.1016/S0140-6736(20)31282-4 10.1001/jama.2020.2648 10.1192/bjo.2021.3 10.1056/NEJMc2008597 10.1056/NEJMp2012910 10.1016/S1474-4422(20)30221-0 10.1136/jnnp-2020-323586 10.1016/S2213-2600(20)30228-9 10.1016/j.psyneuen.2012.09.002 10.1016/j.bbi.2020.12.022 10.1016/j.schres.2020.05.005 10.1016/j.socscimed.2020.113426 10.1148/radiol.2020202222 10.1093/brain/awaa067 10.1212/01.WNL.0000103169.80910.8B 10.1038/s41467-021-22199-9 10.1016/S0140-6736(20)30628-0 10.1038/s41467-021-24365-5 |
| ContentType | Journal Article |
| Copyright | 2021 The Author(s) The Author(s) 2021 The Author(s). 2021 The Author(s) 2021 |
| Copyright_xml | – notice: 2021 The Author(s) – notice: The Author(s) – notice: 2021 The Author(s). – notice: 2021 The Author(s) 2021 |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1016/j.eclinm.2021.101044 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ: Directory of Open Access Journal (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2589-5370 |
| EndPage | 101044 |
| ExternalDocumentID | oai_doaj_org_article_57b44e83c05a49f19e74764fbb3ba457 PMC8298139 34316551 10_1016_j_eclinm_2021_101044 S2589537021003242 1_s2_0_S2589537021003242 |
| Genre | Journal Article |
| GrantInformation | Funding. AH is supported by the UK Dementia Research Institute Care Research and Technology Centre and Biomedical Research Centre at Imperial College London. WT is supported by the EPSRC Centre for Doctoral Training in Neurotechnology. SRC is funded by a Wellcome Trust Clinical Fellowship 110,049/Z/15/Z. JMB is supported by Medical Research Council (MR/N013700/1). MAM, SCRW and PJH are, in part, supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at South Lo |
| GroupedDBID | .1- .FO 0R~ 53G AAEDW AALRI AAMRU AAXUO AAYWO ABMAC ACLIJ ACVFH ADBBV ADCNI ADVLN AEUPX AEXQZ AFPUW AFRHN AFTJW AIGII AITUG AJUYK AKBMS AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS APXCP BCNDV EBS EJD FDB GROUPED_DOAJ HYE M41 OK1 ROL RPM SSZ Z5R 0SF 6I. AACTN NCXOZ AAFTH AFCTW AAYXX CITATION NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c703t-2d604a815e647a3d8ce26fa6b8d0abc2e2de46a05f24660d7ed309a193369ab3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 406 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000704058900018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2589-5370 |
| IngestDate | Fri Oct 03 12:50:38 EDT 2025 Thu Aug 21 18:20:11 EDT 2025 Sun Nov 09 09:22:55 EST 2025 Thu Jan 02 22:35:24 EST 2025 Thu Nov 13 04:31:36 EST 2025 Tue Nov 18 20:51:23 EST 2025 Tue Jul 25 21:01:34 EDT 2023 Sun Feb 23 10:19:47 EST 2025 Tue Aug 26 20:24:14 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | COVID-19 Deficits Online assessment Reasoning Memory Attention Cognition Planning Long covid |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. 2021 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c703t-2d604a815e647a3d8ce26fa6b8d0abc2e2de46a05f24660d7ed309a193369ab3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0003-3947-5532 0000-0002-7413-9772 0000-0002-5176-5420 |
| OpenAccessLink | https://doaj.org/article/57b44e83c05a49f19e74764fbb3ba457 |
| PMID | 34316551 |
| PQID | 2555965866 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_57b44e83c05a49f19e74764fbb3ba457 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8298139 proquest_miscellaneous_2555965866 pubmed_primary_34316551 crossref_citationtrail_10_1016_j_eclinm_2021_101044 crossref_primary_10_1016_j_eclinm_2021_101044 elsevier_sciencedirect_doi_10_1016_j_eclinm_2021_101044 elsevier_clinicalkeyesjournals_1_s2_0_S2589537021003242 elsevier_clinicalkey_doi_10_1016_j_eclinm_2021_101044 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-09-01 |
| PublicationDateYYYYMMDD | 2021-09-01 |
| PublicationDate_xml | – month: 09 year: 2021 text: 2021-09-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | EClinicalMedicine |
| PublicationTitleAlternate | EClinicalMedicine |
| PublicationYear | 2021 |
| Publisher | Elsevier Ltd Elsevier |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
| References | Perego, Callard, Stras, Melville-Jóhannesson, Pope, Alwan (bib0002) 2020 Baig (bib0001) 2020 von Weyhern, Kaufmann, Neff, Kremer (bib0010) 2020; 395 Hampshire, Highfield, Parkin, Owen (bib0027) 2012; 76 Chowkwanyun, Reed (bib0020) 2020 Chamberlain, Grant, Trender, Hellyer, Hampshire (bib0024) 2021; 7 Rogers, Chesney, Oliver (bib0017) 2020; 7 Wu, McGoogan (bib0012) 2020 Helms, Kremer, Merdji (bib0009) 2020; 382 Hampshire, Hellyer, Soreq (bib0025) 2021; 12 Smith (bib0030) 2013; 38 Hampshire (bib0023) 2020 Soreq, Violante, Daws, Hampshire (bib0029) 2021; 12 Ellul, Varatharaj, Nicholson (bib0006) 2020 Zanin, Saraceno, Panciani (bib0016) 2020; 162 P.H England.. Disparities in the risk and outcomes of COVID-19., 2020 Mehta, McAuley, Brown (bib0013) 2020; 395 Sasannejad, Ely, Lahiri (bib0019) 2019; 23 Ellul, Benjamin, Singh (bib0004) 2020 McGurn, Starr, Topfer (bib0026) 2004; 62 Brown, Gray, Lo Monaco (bib0018) 2020; 222 Varatharaj, Thomas, Ellul (bib0005) 2020 Kremer, Lersy, de Seze (bib0015) 2020 Holmes, O'Connor, Perry (bib0031) 2020; 7 Beyrouti, Adams, Benjamin (bib0008) 2020 Kirby (bib0022) 2020; 8 Paterson, Brown, Benjamin (bib0007) 2020 Franke, Ferse, Kreye (bib0014) 2021; 93 Callard, Perego (bib0003) 2021; 268 Toscano, Palmerini, Ravaglia (bib0011) 2020; 382 Jolly, Scott, Sharp, Hampshire (bib0028) 2020; 143 Sasannejad (10.1016/j.eclinm.2021.101044_bib0019) 2019; 23 Varatharaj (10.1016/j.eclinm.2021.101044_bib0005) 2020 10.1016/j.eclinm.2021.101044_bib0021 von Weyhern (10.1016/j.eclinm.2021.101044_bib0010) 2020; 395 Callard (10.1016/j.eclinm.2021.101044_bib0003) 2021; 268 Zanin (10.1016/j.eclinm.2021.101044_bib0016) 2020; 162 McGurn (10.1016/j.eclinm.2021.101044_bib0026) 2004; 62 Jolly (10.1016/j.eclinm.2021.101044_bib0028) 2020; 143 Chamberlain (10.1016/j.eclinm.2021.101044_bib0024) 2021; 7 Baig (10.1016/j.eclinm.2021.101044_bib0001) 2020 Toscano (10.1016/j.eclinm.2021.101044_bib0011) 2020; 382 Wu (10.1016/j.eclinm.2021.101044_bib0012) 2020 Kirby (10.1016/j.eclinm.2021.101044_bib0022) 2020; 8 Hampshire (10.1016/j.eclinm.2021.101044_bib0025) 2021; 12 Hampshire (10.1016/j.eclinm.2021.101044_bib0027) 2012; 76 Soreq (10.1016/j.eclinm.2021.101044_bib0029) 2021; 12 Ellul (10.1016/j.eclinm.2021.101044_bib0004) 2020 Beyrouti (10.1016/j.eclinm.2021.101044_bib0008) 2020 Kremer (10.1016/j.eclinm.2021.101044_bib0015) 2020 Ellul (10.1016/j.eclinm.2021.101044_bib0006) 2020 Brown (10.1016/j.eclinm.2021.101044_bib0018) 2020; 222 Chowkwanyun (10.1016/j.eclinm.2021.101044_bib0020) 2020 Franke (10.1016/j.eclinm.2021.101044_bib0014) 2021; 93 Hampshire (10.1016/j.eclinm.2021.101044_bib0023) 2020 Smith (10.1016/j.eclinm.2021.101044_bib0030) 2013; 38 Rogers (10.1016/j.eclinm.2021.101044_bib0017) 2020; 7 Perego (10.1016/j.eclinm.2021.101044_bib0002) 2020 Holmes (10.1016/j.eclinm.2021.101044_bib0031) 2020; 7 Paterson (10.1016/j.eclinm.2021.101044_bib0007) 2020 Mehta (10.1016/j.eclinm.2021.101044_bib0013) 2020; 395 Helms (10.1016/j.eclinm.2021.101044_bib0009) 2020; 382 |
| References_xml | – year: 2020 ident: bib0006 article-title: Defining causality in COVID-19 and neurological disorders publication-title: J Neurol Neurosurg Psychiatry – volume: 7 start-page: e47 year: 2021 ident: bib0024 article-title: Post-traumatic stress disorder symptoms in COVID-19 survivors: online population survey publication-title: BJPsych Open – year: 2020 ident: bib0008 article-title: Characteristics of ischaemic stroke associated with COVID-19 publication-title: J Neurol Neurosurg Psychiatry – volume: 268 year: 2021 ident: bib0003 article-title: How and why patients made Long Covid publication-title: Soc Sci Med – volume: 62 start-page: 1184 year: 2004 end-page: 1186 ident: bib0026 article-title: Pronunciation of irregular words is preserved in dementia, validating premorbid IQ estimation publication-title: Neurology – volume: 395 start-page: 1033 year: 2020 end-page: 1034 ident: bib0013 article-title: COVID-19: consider cytokine storm syndromes and immunosuppression publication-title: Lancet – year: 2020 ident: bib0007 article-title: The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings publication-title: Brain – volume: 38 start-page: 744 year: 2013 end-page: 751 ident: bib0030 article-title: Twenty-five years of research on the behavioural malaise associated with influenza and the common cold publication-title: Psychoneuroendocrinology – year: 2020 ident: bib0005 article-title: Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study publication-title: Lancet Psychiatry – volume: 23 start-page: 352 year: 2019 ident: bib0019 article-title: Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms publication-title: Crit Care – volume: 93 start-page: 415 year: 2021 end-page: 419 ident: bib0014 article-title: High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms publication-title: Brain Behav Immun – volume: 222 start-page: 79 year: 2020 end-page: 87 ident: bib0018 article-title: The potential impact of COVID-19 on psychosis: a rapid review of contemporary epidemic and pandemic research publication-title: Schizophr Res – volume: 8 start-page: 547 year: 2020 end-page: 548 ident: bib0022 article-title: Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities publication-title: Lancet Respir Med – year: 2020 ident: bib0023 article-title: Great british intelligence test protocol – year: 2020 ident: bib0020 article-title: Racial health disparities and COVID-19-caution and context publication-title: N Engl J Med – year: 2020 ident: bib0001 article-title: Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers publication-title: J Med Virol – volume: 143 start-page: 1158 year: 2020 end-page: 1176 ident: bib0028 article-title: Distinct patterns of structural damage underlie working memory and reasoning deficits after traumatic brain injury publication-title: Brain – volume: 162 start-page: 1491 year: 2020 end-page: 1494 ident: bib0016 article-title: SARS-CoV-2 can induce brain and spine demyelinating lesions publication-title: Acta Neurochir – volume: 7 start-page: 611 year: 2020 end-page: 627 ident: bib0017 article-title: Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic publication-title: Lancet Psychiatry – volume: 76 start-page: 1225 year: 2012 end-page: 1237 ident: bib0027 article-title: Fractionating human intelligence publication-title: Neuron – year: 2020 ident: bib0004 article-title: Neurological associations of COVID-19 publication-title: Lancet Neurol – year: 2020 ident: bib0015 article-title: Brain MRI findings in severe COVID-19: a retrospective observational study publication-title: Radiology – year: 2020 ident: bib0002 article-title: Why the patient-made term 'long Covid' is needed – volume: 382 start-page: 2268 year: 2020 end-page: 2270 ident: bib0009 article-title: Neurologic features in severe SARS-CoV-2 infection publication-title: N Engl J Med – year: 2020 ident: bib0012 article-title: Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the chinese center for disease control and prevention publication-title: JAMA – volume: 395 start-page: e109 year: 2020 ident: bib0010 article-title: Early evidence of pronounced brain involvement in fatal COVID-19 outcomes publication-title: Lancet – reference: P.H England.. Disparities in the risk and outcomes of COVID-19., 2020 – volume: 382 start-page: 2574 year: 2020 end-page: 2576 ident: bib0011 article-title: Guillain-barre syndrome associated with SARS-CoV-2 publication-title: N Engl J Med – volume: 12 start-page: 4111 year: 2021 ident: bib0025 article-title: Associations between dimensions of behaviour, personality traits, and mental-health during the COVID-19 pandemic in the United Kingdom publication-title: Nat Commun – volume: 12 start-page: 2072 year: 2021 ident: bib0029 article-title: Neuroimaging evidence for a network sampling theory of individual differences in human intelligence test performance publication-title: Nat Commun – volume: 7 start-page: 547 year: 2020 end-page: 560 ident: bib0031 article-title: Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science publication-title: Lancet Psychiatry – volume: 162 start-page: 1491 issue: 7 year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0016 article-title: SARS-CoV-2 can induce brain and spine demyelinating lesions publication-title: Acta Neurochir doi: 10.1007/s00701-020-04374-x – year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0007 article-title: The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings publication-title: Brain doi: 10.1093/brain/awaa240 – volume: 7 start-page: 547 issue: 6 year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0031 article-title: Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(20)30168-1 – volume: 23 start-page: 352 issue: 1 year: 2019 ident: 10.1016/j.eclinm.2021.101044_bib0019 article-title: Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms publication-title: Crit Care doi: 10.1186/s13054-019-2626-z – volume: 7 start-page: 611 issue: 7 year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0017 article-title: Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(20)30203-0 – year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0002 – year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0005 article-title: Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(20)30287-X – volume: 382 start-page: 2574 issue: 26 year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0011 article-title: Guillain-barre syndrome associated with SARS-CoV-2 publication-title: N Engl J Med doi: 10.1056/NEJMc2009191 – volume: 76 start-page: 1225 issue: 6 year: 2012 ident: 10.1016/j.eclinm.2021.101044_bib0027 article-title: Fractionating human intelligence publication-title: Neuron doi: 10.1016/j.neuron.2012.06.022 – year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0006 article-title: Defining causality in COVID-19 and neurological disorders publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2020-323667 – volume: 395 start-page: e109 issue: 10241 year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0010 article-title: Early evidence of pronounced brain involvement in fatal COVID-19 outcomes publication-title: Lancet doi: 10.1016/S0140-6736(20)31282-4 – year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0001 article-title: Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers publication-title: J Med Virol – year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0012 article-title: Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the chinese center for disease control and prevention publication-title: JAMA doi: 10.1001/jama.2020.2648 – year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0023 – volume: 7 start-page: e47 issue: 2 year: 2021 ident: 10.1016/j.eclinm.2021.101044_bib0024 article-title: Post-traumatic stress disorder symptoms in COVID-19 survivors: online population survey publication-title: BJPsych Open doi: 10.1192/bjo.2021.3 – volume: 382 start-page: 2268 issue: 23 year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0009 article-title: Neurologic features in severe SARS-CoV-2 infection publication-title: N Engl J Med doi: 10.1056/NEJMc2008597 – year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0020 article-title: Racial health disparities and COVID-19-caution and context publication-title: N Engl J Med doi: 10.1056/NEJMp2012910 – year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0004 article-title: Neurological associations of COVID-19 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(20)30221-0 – year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0008 article-title: Characteristics of ischaemic stroke associated with COVID-19 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2020-323586 – volume: 8 start-page: 547 issue: 6 year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0022 article-title: Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(20)30228-9 – volume: 38 start-page: 744 issue: 6 year: 2013 ident: 10.1016/j.eclinm.2021.101044_bib0030 article-title: Twenty-five years of research on the behavioural malaise associated with influenza and the common cold publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2012.09.002 – volume: 93 start-page: 415 year: 2021 ident: 10.1016/j.eclinm.2021.101044_bib0014 article-title: High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2020.12.022 – ident: 10.1016/j.eclinm.2021.101044_bib0021 – volume: 222 start-page: 79 year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0018 article-title: The potential impact of COVID-19 on psychosis: a rapid review of contemporary epidemic and pandemic research publication-title: Schizophr Res doi: 10.1016/j.schres.2020.05.005 – volume: 268 year: 2021 ident: 10.1016/j.eclinm.2021.101044_bib0003 article-title: How and why patients made Long Covid publication-title: Soc Sci Med doi: 10.1016/j.socscimed.2020.113426 – year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0015 article-title: Brain MRI findings in severe COVID-19: a retrospective observational study publication-title: Radiology doi: 10.1148/radiol.2020202222 – volume: 143 start-page: 1158 issue: 4 year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0028 article-title: Distinct patterns of structural damage underlie working memory and reasoning deficits after traumatic brain injury publication-title: Brain doi: 10.1093/brain/awaa067 – volume: 62 start-page: 1184 issue: 7 year: 2004 ident: 10.1016/j.eclinm.2021.101044_bib0026 article-title: Pronunciation of irregular words is preserved in dementia, validating premorbid IQ estimation publication-title: Neurology doi: 10.1212/01.WNL.0000103169.80910.8B – volume: 12 start-page: 2072 issue: 1 year: 2021 ident: 10.1016/j.eclinm.2021.101044_bib0029 article-title: Neuroimaging evidence for a network sampling theory of individual differences in human intelligence test performance publication-title: Nat Commun doi: 10.1038/s41467-021-22199-9 – volume: 395 start-page: 1033 issue: 10229 year: 2020 ident: 10.1016/j.eclinm.2021.101044_bib0013 article-title: COVID-19: consider cytokine storm syndromes and immunosuppression publication-title: Lancet doi: 10.1016/S0140-6736(20)30628-0 – volume: 12 start-page: 4111 issue: 1 year: 2021 ident: 10.1016/j.eclinm.2021.101044_bib0025 article-title: Associations between dimensions of behaviour, personality traits, and mental-health during the COVID-19 pandemic in the United Kingdom publication-title: Nat Commun doi: 10.1038/s41467-021-24365-5 |
| SSID | ssj0002048960 |
| Score | 2.6353195 |
| Snippet | There is growing concern about possible cognitive consequences of COVID-19, with reports of ‘Long COVID’ symptoms persisting into the chronic phase and case... AbstractBackgroundThere is growing concern about possible cognitive consequences of COVID-19, with reports of ‘Long COVID’ symptoms persisting into the chronic... There is growing concern about possible cognitive consequences of COVID-19, with reports of 'Long COVID' symptoms persisting into the chronic phase and case... Background: There is growing concern about possible cognitive consequences of COVID-19, with reports of ‘Long COVID’ symptoms persisting into the chronic phase... |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 101044 |
| SubjectTerms | Attention Cognition COVID-19 Deficits Internal Medicine Long covid Memory Online assessment Planning Reasoning Research Paper |
| Title | Cognitive deficits in people who have recovered from COVID-19 |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2589537021003242 https://www.clinicalkey.es/playcontent/1-s2.0-S2589537021003242 https://dx.doi.org/10.1016/j.eclinm.2021.101044 https://www.ncbi.nlm.nih.gov/pubmed/34316551 https://www.proquest.com/docview/2555965866 https://pubmed.ncbi.nlm.nih.gov/PMC8298139 https://doaj.org/article/57b44e83c05a49f19e74764fbb3ba457 |
| Volume | 39 |
| WOSCitedRecordID | wos000704058900018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ: Directory of Open Access Journal (DOAJ) customDbUrl: eissn: 2589-5370 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002048960 issn: 2589-5370 databaseCode: DOA dateStart: 20180101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA96iPgi5_ee51HB10CapmnyeN4HCnoKHse-haSdsntIV65757_vTNIuWxXWB1_z0ZDJTPMbMvMbxt7ligq95S2H1iiutAe0ORF4TkwpeF-GNtY6vPpUXVyY-dx-3Sr1RTFhiR44CQ4d9qAUmKIWpVe2zS0gANaqDaEIXpUxj1xUdsuZuo7Pa8rYmCIsS2N5WVRizJuLwV1AeYeUiC5zahJKTe6lSN8_uZ7-hJ-_R1FuXUvn--zxgCez47SPJ-wedE_Zw8_Di_kzRpTVKT4oa4DYItZ9tuyyFDie_VyssoXHPvKL76hsZ0b5JtnJl6uPpzy3z9nl-dnlyQc-lEzgNZrumstGC-VNXoJWlS8aU4PUrdfBNMKHWoJsAA9ElHgEWoumgqYQ1iOKK7T1oXjB9rpVB69YBiKIyssSDHEWNpqQmqqVCD4EdJlgxopRXq4e6MSpqsV3N8aNXbskZUdSdknKM8Y3s34kOo0d49_TUWzGEhl2bEAVcYOKuF0qMmPleJBuzDfFPyR-aLlj8epv86AfzLx3ueulE-4bKRnpGPrPghDq9swBySSE8g9rvh01zaGh0-uN72B12zv0_Upi6tF6xl4mzduIpSBCA8S-uO5EJydym_Z0y0UkEzfSGvQCDv6HoF-zR7SVFIJ3yPbWN7fwhj2o79bL_uaI3a_m5ija6S9mJTxA |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cognitive+deficits+in+people+who+have+recovered+from+COVID-19&rft.jtitle=EClinicalMedicine&rft.au=Hampshire%2C+Adam&rft.au=Trender%2C+William&rft.au=Chamberlain%2C+Samuel+R&rft.au=Jolly%2C+Amy+E.&rft.date=2021-09-01&rft.pub=Elsevier+Ltd&rft.issn=2589-5370&rft.eissn=2589-5370&rft.volume=39&rft_id=info:doi/10.1016%2Fj.eclinm.2021.101044&rft.externalDocID=S2589537021003242 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F25895370%2FS2589537021X00090%2Fcov150h.gif |